enVVeno Medical enters ATM offering agreement for up to $50M of common stock

enVVeno Medical Corp

Agreement with Ladenburg Thalmann allows sale of up to $50M of common stock from time to time.
Shares sold at market prices; agent receives 3% commission on gross proceeds.
ATM shares issued under existing effective S-3 registration statement (filed Aug 23, 2023).
Company has no obligation to sell shares; may suspend or terminate the program at any time.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.